News archive
New MSc in Cognitive Brain Imaging
A new MSc course has been launched by the School of Psychological Sciences which is designated to prepare individuals for various careers in functional neuroimaging (April 2009).
Centre research to be presented ay two prestigious conference this summer
We are delighted to announce that abstracts from the study Serotonin transporter (SERT) occupancy by oral sibutramine in the living human brain using 11C-DASB PET have been awarded oral presentations at two of the most prestigious conferences in the field of PET molecular imaging (April 2009).
WMIC appoints new Associate Director
Professor Alan Jackson to take leading role in cancer studies and magnetic resonance scanning activities (January 2009).
Recruitment commences on Euripides project
Volunteer recruitment on a Pan-European FP7-funded research study commences (December 2008).
Third MRI Scanner at WMIC
The University installs its third MRI scanner second 1.5T at the Wolfson Molecular Imaging Centre (September 2008).
Congratulations to Alavi-Mandell award winner
WMIC-based research Dr David Coope has won an award from the Society of Nuclear Medicine (July 2008).
WMIC director elected to prestigious post in the Society of Nuclear Medicine
We are pleased to announce that Professor Karl Herholz, Director of the Wolfson Molecular Imaging Centre, has been elected to the position of Vice President-elect of the Society of Nuclear Medicine Brain Imaging Council (July 2008).
Hello Magnetic Resonance Imaging Facility
TIU becomes the Magnetic Resonance Imaging Facility (May 2008).
New Medicines and Healthcare products Regulatory Agency License Award
The Wolfson Molecular Imaging Centre has been awarded new license by the MHRA (May 2008).
New MR scanning capability at the Wolfson Molecular Imaging Centre
A new MRI scanner is to be installed to further encourage and facilitate multi-modality imaging studies (May 2008).
WMIC 'linked' with the Christie NHS Trust
New corridor under construction to facilitate better patient access to WMIC from the Christie Hospital (May 2008).
New pan-European research project
Today marks the start of a major new pan-European research project, using expertise and facilities at the Wolfson Molecular Imaging Centre and twelve other academic European partner sites (February 2008).
First receptor study with arterial input function performed at the WMIC
Major milestone for the quantification of PET data passed (December 2007).
New technology innovations at WMIC
Recent novel advancements in the areas of radiochemistry and clinical PET scanning research (August 2007).
Centre collaborates with top cancer imaging specialist
Wolfson Molecular Imaging Centre collaborates with top specialist (July 2007).
Cantre takes delivery of 'next generation' high performance mass spectrometry equipment
The Wolfson Molecular Imaging Centre has acquired a new mass spectrometer from Kratos (Shimadzu Biotech) (June 2007).
Successful debut for in-house radiotracer production
The WMIC today conducted its first scan in a clinical study using the tracer PK11195 – a C-11 radiotracer manufactured under its newly-acquired MHRA license (April 2007).
Centre hosts visit by the University Vice-Chancellor and President
The WMIC received the confident endorsement of Professor Alan Gilbert, Vice-Chancellor and President of the University (April 2007).
New study investigating tumour irradiation and brain function gets underway
The WMIC begins scanning patients as part of a study investigating brain metasteses (March 2007).
Centre welcomes US biotech mission
The WMIC hosted a visit from a delegation of US biotech company executives organised by the UK North West Development Agency (February 2007).
MHRA specials license extended to include GMP tracers
The WMIC is awarded a license to produce its own radiotracers (December 2006).
Another significant step forward in PET research
Radiolabelled carbon monoxide used for the first time in the Centre (November 2006).
First patient brain scan attracts media interest
First brain scan carried out on a patient volunteer (November 2006).
Membership of European Network of Excellence
WMIC granted membership of European Network of Excellence in Diagnostic Molecular Imaging (October 2006).
Another leap forward for WMIC
First brain study begins investigating early dementia (September 2006).
Phase one study begins at WMIC
An early stage cancer trial has begun investigating a promising new drug (July 2006).
Tea for 100 at House of Lords bash
Event organised to celebrate launch of WMIC's operational phase (June 2006).
Centre goes live with first scan
First body scan using cutting-edge PET techniques undertaken as part of Cancer Research UK study (June 2006).
Home Office licensed
The Home Office has agreed the pre-clinical licenses with the WMIC for service and projects allowing the Centre to undertake PET molecular imaging (March/July 2006).
MHRA specials license obtained
The Wolfson Molecular Imaging Centre has obtained a specials license from the Medicines and Healthcare products Regulatory Agency to use radio-labelled tracers (March 2006).
Protein Synthesis Workshop
A workshop entitled 'Protein synthesis and axonal transport: In-vivo measurements in brain disease' was held at the Manchester Conference Centre as part of the Alzheimer Research Trust (ART) Network Conference this week (March 2006).
European Regional Development Fund award<
The Wolfson Molecular Imaging Centre in Manchester has been granted a major award of over three quarters of a million pounds by the European Regional Development Fund (December 2004).
Bionow (the NWDA's biotechnology cluster) awards WMIC £0.5 million
Bionow, the Northwest Regional Development Agency’s (NWDA) biotechnology cluster group, is investing £500,000 towards new equipment for The University of Manchester’s Wolfson Molecular Imaging Centre (WMIC) (September 2004).
Centre joins European Network of Excellence
The Centre becomes a partner of the European Molecular Imaging Laboratories (EMIL), a European network established to encourage the early stage diagnosis and treatment of cancer (August 2004).
Centre becomes member of BioCare consortium
The Centre has joined a consortium of European institutions set up to encourage molecular imaging for biologically optimised cancer therapy (July 2004).
Lord Sainsbury visits the CentreA high-level delegation led by Chairman of the Board of Trade Lord Sainsbury has visited the Wolfson Molecular Imaging Centre on the Christie Hospital site in Manchester, to see the world-beating facilities that have been set up there (June 2004).
Cyclotron, hot cell and delivery system installations begin
Installation continues at the new world-beating Wolfson Molecular Imaging Centre, where around £3million has been invested in the installation of radiochemistry production facilities (Summer 2004).
Scanners installation begins
Two ‘human scanners’ with a combined cost of just over £2million have been installed at the Wolfson Molecular Imaging Centre in Manchester (January 2004).
Authorised to handle radiation
The Environment Agency has given the Wolfson Molecular Imaging Centre in South Manchester authorisation to handle radiation within its environment (December 2003).
New world begins with the end of Phase 1
The first phase of the Wolfson Molecular Imaging Centre’s building programme has been completed and a lease signed with Christie Hospital NHS Trust, allowing staff to enter the building for the first time (November 2003).
Research Council grants
The Medical Research Council (MRC) and the Engineering and Physical Sciences Research Council (EPSRC) have jointly pledged approximately £3million to the WMIC, in the form of a capital grant (July 2003).
University banks on new Centre
The University of Manchester has provided a significant funding boost to the Wolfson Molecular Imaging Centre as the project nears the end of its first phase (June 2003).